Improving diagnosis and treatment for rare pediatric viral diseases.
Pilot and Feasibility Core
This study is all about finding better ways to diagnose and treat rare viral infections in children, like congenital cytomegalovirus and neonatal herpes, by working with researchers and sharing ideas, so we can help kids get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915389 on NIH RePORTER |
What this research studies
This research focuses on reducing the impact of rare viral diseases in children, specifically congenital cytomegalovirus, neonatal herpes simplex virus, and neonatal enterovirus infections. By collecting data from multiple sites, the project aims to enhance diagnosis, prepare for clinical trials, and improve treatment options. Each year, a new project will be supported that aligns with these goals, providing mentorship and resources to junior researchers in the field. The initiative emphasizes innovation and collaboration to advance knowledge and treatment strategies for these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants diagnosed with congenital cytomegalovirus, neonatal herpes simplex virus, or neonatal enterovirus infections.
Not a fit: Patients with viral infections not covered by this research, or those outside the neonatal age range, may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and treatment options for infants affected by serious viral infections.
How similar studies have performed: Previous research in similar areas has shown promise in improving outcomes for pediatric viral infections, indicating that this approach could be effective.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Whitley, Richard J. — University of Alabama at Birmingham
- Study coordinator: Whitley, Richard J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.